Treatment of chronic hepatitis B with lamivudine in renal allograft recipients
- 14 September 2000
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (6) , 1369-1370
- https://doi.org/10.1016/s0041-1345(00)01260-4
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- TREATMENT OF CHRONIC HEPATITIS B WITH LAMIVUDINE IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1998
- EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1997
- Serum HBeAg quantitation during antiviral therapy for chronic hepatitis BJournal of Medical Virology, 1997
- BENEFICIAL EFFECT OF LAMIVUDINE IN RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATIONTransplantation, 1997
- Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled TrialHepatology, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Co-infection by hepatitis B virus and hepatitis C virus in renal transplantation: morbidity and mortality in 1098 patientsNephrology Dialysis Transplantation, 1995
- Mechanisms of Action of InterferonsSeminars in Liver Disease, 1989